24
Participants
Start Date
July 25, 2018
Primary Completion Date
December 31, 2023
Study Completion Date
May 31, 2024
Enoxaparin
Enoxaparin is used for prevention of blood clots following abdominal or orthopedic surgery and in medical patients with restricted mobility during acute illness
Enoxaparin + Rosuvastatin
"Rosuvastatin is an anti-cholesterol medication that is FDA (the U.S. Food and Drug Administration) approved to lower cholesterol and reduce the risk of arterial blood clots. There is evidence that rosuvastatin can lower the risk of venous blood clots in healthy individuals~Enoxaparin is used for prevention of blood clots following abdominal or orthopedic surgery and in medical patients with restricted mobility during acute illness"
Thromboprophylaxis
standard of care therapy
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
National Institutes of Health (NIH)
NIH
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Beth Israel Deaconess Medical Center
OTHER